Anti Viral
-
Ledibiox®
Ledibiox is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
-
Daklibiox®
Daklibiox is indicated for use with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection.
-
Sobiovir®
Sobiovir indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.
-
Biovirapine®
Nevirapine: Biovirapine is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1-infection.
-
Valbiovir®
Valacyclovir: Herpes genitalis Herpes zoster
-
Cytobiovir®
Valgancyclovir: For treatment of CMV-infections
-
Tenobiovir®
Tenofovir disoproxil fumarate:Tenobiovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection or chronic hepatitis B virus infection in patients who are also infected with HIV.
-
Efabiovir®
Efabiovir in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.
-
Co-Biovir®
Zidovudine / Lamivudine: This Combination is indicated in the treatment of HIV infection.
-
Biofovir®
Adefovir: Biofovir is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.